Sign in

CIK 0001468929 · <br>Emerging growth company

NEXGEL, INC.

Sign in to watch
Ticker
NXGL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264042544
Phone
215 702-8550
Business address
2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
Former names
NEXGEL, INC., AquaMed Technologies, Inc.

Securities

  • NXGL Common Stock Nasdaq
  • NXGLW Warrant Nasdaq
  1. 4 Planned sale Director sold 7,697 shares at $2.36 ($18,149)
  2. 4 Open-market sale Chief Executive Officer sold 4,000 shares at $2.47 ($9,896)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale Director sold 3,000 shares at $2.57 ($7,704)
  9. 4 Open-market sale Chief Executive Officer sold 4,000 shares at an average $2.36 ($9,439)
  10. 4 Open-market sale Chief Executive Officer sold 2,000 shares at an average $2.31 ($4,613)
  11. 4 Open-market sale Chief Executive Officer sold 1,000 shares at $2.22 ($2,220)
  12. 4 Open-market sale Chief Executive Officer sold 1,000 shares at $2.58 ($2,575)
  13. 4 Planned sale Director sold 3,000 shares at $2.69 ($8,062)
  14. 4 Planned sale Director sold 3,000 shares at $2.61 ($7,825)
  15. 4 Planned sale Chief Executive Officer sold 4,000 shares at $3.01 ($12,038)
  16. 4 Planned sale Director sold 3,000 shares at $2.87 ($8,621)
  17. 4 Planned sale Chief Executive Officer sold 4,000 shares at $3.16 ($12,639)
  18. 4 Grant or award Director acquired 2,500 shares (grant or award)
  19. 4 Planned sale Director sold 3,000 shares at $3.27 ($9,798)
  20. 4 Planned sale Chief Executive Officer sold 4,000 shares at $3.64 ($14,558)

Page 2 of 6 · 115 filings